Medicine
Showing 1,741-1,760 of 2,393 Results
-
Fauzia Riaz, MD, MHS
Assistant Professor of Medicine (Oncology)
BioDr. Riaz is advancing biomarker-driven precision medicine in breast cancer through innovative clinical trials that integrate cutting-edge therapeutics and molecular insights.
Her research focuses on circulating tumor DNA (ctDNA) to detect minimal residual disease (MRD) in early-stage breast cancer, aiming to guide personalized treatment strategies. She is also developing novel approaches to enhance immunotherapy efficacy by modulating the tumor microenvironment, including early-phase trials that combine immunotherapy with radiotherapy. As an Assistant Professor at Stanford University School of Medicine, Dr. Riaz is committed to ensuring that these next-generation therapies are accessible to all patients.. -
Tia Rich, PhD
Director, Contemplation by Design, Med/SPRC - Division
Current Role at StanfordLecturer, School of Medicine, Community Health and Prevention Research
Director, Stanford Contemplation by Design -
Stephen Richmond
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Stephen Richmond is a family physician, educator, and health justice advocate with specific interest in racial equity in medicine. He currently serves as a clinical assistant professor of medicine in the Division of Primary Care & Population Health (PCPH) in the Stanford Department of Medicine. He completed his A.S. at Solano Community College, B.A. in Molecular & Cell Biology at UC Berkeley, M.P.H. at Harvard T.H. Chan School of Public Health, and his M.D. at David Geffen School of Medicine, UCLA. He is a graduate of the UCSF-San Francisco General Hospital Family & Community Medicine Residency Program. As a clinician, Dr. Richmond cares for individuals of all ages with a wide range of acute and chronic illnesses. He is especially passionate about providing high quality, evidenced-based care to underserved communities.
-
Brian Ring
Affiliate, Medicine - Med/Stanford Prevention Research Center
BioDr. Brian Ring received his PhD in molecular biology and genetics from Cornell University and completed his post-doctoral training at Stanford University School of Medicine.
Dr. Ring is an experienced bioinformatics leader with many years in oncology-focused research and diagnostics, including the development of several clinically utilized gene expression-based companion diagnostics. He has also been the CSO and founder of multiple companies operating in the health field.
Currently, Dr. Ring is an affiliate in the school of Medicine - Med/Stanford Prevention Research Center. -
Sonia Rios-Ventura
Family Health Navigator, Medicine - Med/Oncology
BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.
She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing. -
Norman Rizk
Berthold and Belle N. Guggenhime Professor, Emeritus
Current Research and Scholarly InterestsI am interested in the prevention and control of critical care-related illnesses and complications, including ventilator-associated pneumonia, spread of nosocomial infections, and prognosis of multiple organ system failure in intensive care units. Infections and complications of therapy in immunocompromised hosts, including effects of chemotherapy and hematopoetic stem cell transplants is another interest.
-
Farhana Rob, DO
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Farhana Rob is a board-certified, fellowship-trained family medicine doctor with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Primary Care and Population Health at Stanford University School of Medicine.
Dr. Rob provides personalized and compassionate primary care for people ranging from newborns to older adults. She specializes in women’s health and maternity care, managing conditions such as heavy menstrual bleeding, pregnancy-induced hypertension, and gestational diabetes. She also has expertise in birth control, discussing and providing options particularly for adolescents and postpartum mothers. Dr. Rob also specializes in minor injuries and musculoskeletal problems, providing therapies such as laceration repair, tendon and joint injections, and trigger point injections.
Dr. Rob emphasizes preventive care and early diagnosis through routine and diagnostic screenings. She strives to empower them to become active participants in their health care. She is open to discussing alternative and natural treatments to support holistic healing. Dr. Rob also enjoys teaching and has mentored medical students and residents throughout her career.
Dr. Rob has published research on heart failure in peer-reviewed journals including the Journal of Cardiovascular Electrophysiology. She shared her findings on using ultrasound to estimate birthweight at the American Academy of Family Physicians Family-Centered Pregnancy Care Conference. She has also written about heavy menstrual bleeding for The 5-Minute Clinical Consult, a physician guidebook that focuses on evidence-based medicine.
Dr. Rob is a member of the American Academy of Family Physicians, the American Board of Family Medicine, and the American Medical Association. -
William H. Robinson, MD PhD
James W. Raitt, M.D. Professor
Current Research and Scholarly InterestsOur lab investigates the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and osteoarthritis.
The overriding objectives of our laboratory are:
1. To elucidate the mechanisms underlying autoimmune and rheumatic diseases.
2. To investigate the role of innate immune inflammation in osteoarthritis.
3. To develop novel diagnostics and therapeutics -
Jennifer Robinson
Associate Director, Medicine - Med/Stanford Prevention Research Center
Current Role at StanfordAssociate Director, Nutrition Studies Group
-
Thomas Robinson
The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.
-
Nancy Robles, NP-C
Affiliate, Medicine - Med/Cardiovascular Medicine
BioI'm an advanced practice provider with a focus in inherited cardiovascular disease, neuromuscular disease associated cardiomyopathies, advanced heart failure, and sports cardiology. I also have a strong background in Emergency Medicine and trauma. Hablo Espanol.
-
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
